Cat. No.: X22-05-ZQ270

Neogambogic acid

Synonym: 93772-31-7; Neogambogic acid; Neo-gambogic acid; (E)-4-[10,12-Dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,11,15-tetraen-19-yl]-2-methylbut-2-enoic acid

  • CAS Number: 93772-31-7
  • Compound CID: 6438568
Product Size
20 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Neogambogic acid, an active ingredient, induces apoptosis and has an anticancer effect. Neogambogic acid has significant inhibitory activity toward methicillin-resistant Staphylococcus aureus (MRSA). This product can be used for content determination, identification, and pharmacological experiments, etc.
Molecular Weight
646.776
Molecular Formula
C38H46O9
Purity
≥98%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Form
Powder
Identity
Confirmed by MS and NMR.
Applications
Neogambogic acid can be used for content determination, identification, and pharmacological experiments, etc.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.